These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 17410109)

  • 21. An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia.
    Erman M; Seiden D; Zammit G; Sainati S; Zhang J
    Sleep Med; 2006 Jan; 7(1):17-24. PubMed ID: 16309958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic and pharmacodynamic evaluation of ramelteon : an insomnia therapy.
    Spadoni G; Bedini A; Lucarini S; Mor M; Rivara S
    Expert Opin Drug Metab Toxicol; 2015 Jul; 11(7):1145-56. PubMed ID: 25956235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and clinical safety of ramelteon: an evidence-based review.
    Sateia MJ; Kirby-Long P; Taylor JL
    Sleep Med Rev; 2008 Aug; 12(4):319-32. PubMed ID: 18603221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New hypnotics ramelteon for the treatment of insomniacs with circadian rhythm disturbance].
    Mishima K
    Nihon Rinsho; 2012 Jun; 70(6):1069-78. PubMed ID: 22690618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ramelteon for the treatment of insomnia in adults: a systematic review and meta-analysis.
    Kuriyama A; Honda M; Hayashino Y
    Sleep Med; 2014 Apr; 15(4):385-92. PubMed ID: 24656909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia.
    Roth T; Seiden D; Wang-Weigand S; Zhang J
    Curr Med Res Opin; 2007 May; 23(5):1005-14. PubMed ID: 17519067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Delirium, insomnia in hospitalization and ramelteon].
    Ito T
    Nihon Rinsho; 2012 May; 70(5):907-13. PubMed ID: 22620020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticonvulsant effects of the selective melatonin receptor agonist ramelteon.
    Fenoglio-Simeone K; Mazarati A; Sefidvash-Hockley S; Shin D; Wilke J; Milligan H; Sankar R; Rho JM; Maganti R
    Epilepsy Behav; 2009 Sep; 16(1):52-7. PubMed ID: 19682955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of ramelteon and triazolam in a mouse genetic model of early morning awakenings.
    Wisor JP; Jiang P; Striz M; O'Hara BF
    Brain Res; 2009 Nov; 1296():46-55. PubMed ID: 19664610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ramelteon (Rozerem) for insomnia.
    Med Lett Drugs Ther; 2005 Nov; 47(1221):89-91. PubMed ID: 16267494
    [No Abstract]   [Full Text] [Related]  

  • 31. Investigational melatonin receptor agonists.
    Hardeland R
    Expert Opin Investig Drugs; 2010 Jun; 19(6):747-64. PubMed ID: 20408738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of ramelteon 8 mg on objective sleep latency in adults with chronic insomnia on nights 1 and 2: pooled analysis.
    Wang-Weigand S; McCue M; Ogrinc F; Mini L
    Curr Med Res Opin; 2009 May; 25(5):1209-13. PubMed ID: 19327100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ramelteon.
    McGechan A; Wellington K
    CNS Drugs; 2005; 19(12):1057-65; discussion 1066-7. PubMed ID: 16332146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ramelteon (TAK-375), a selective MT1/MT2-receptor agonist, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment.
    Roth T; Stubbs C; Walsh JK
    Sleep; 2005 Mar; 28(3):303-7. PubMed ID: 16173650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circadian periods of sensitivity for ramelteon on the onset of running-wheel activity and the peak of suprachiasmatic nucleus neuronal firing rhythms in C3H/HeN mice.
    Rawashdeh O; Hudson RL; Stepien I; Dubocovich ML
    Chronobiol Int; 2011 Feb; 28(1):31-8. PubMed ID: 21182402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular cloning and pharmacological characterization of monkey MT1 and MT2 melatonin receptors showing high affinity for the agonist ramelteon.
    Nishiyama K; Shintani Y; Hirai K; Yoshikubo S
    J Pharmacol Exp Ther; 2009 Sep; 330(3):855-63. PubMed ID: 19556449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoimmune hepatitis in association with ramelteon.
    Fourman LT; Robert Meyer B
    J Clin Gastroenterol; 2013 Aug; 47(7):651-4. PubMed ID: 23632362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melatonin and sleep in aging population.
    Pandi-Perumal SR; Zisapel N; Srinivasan V; Cardinali DP
    Exp Gerontol; 2005 Dec; 40(12):911-25. PubMed ID: 16183237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Augmentation with ramelteon to achieve remission in geriatric major depression.
    Furuya M; Kunishige K; Miyaoka T; Wake R; Liaury K; Sadakuni F; Horiguchi J
    Psychiatry Clin Neurosci; 2012 Feb; 66(1):81-2. PubMed ID: 22250616
    [No Abstract]   [Full Text] [Related]  

  • 40. Therapeutic options for sleep-maintenance and sleep-onset insomnia.
    Morin AK; Jarvis CI; Lynch AM
    Pharmacotherapy; 2007 Jan; 27(1):89-110. PubMed ID: 17192164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.